0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query qyresearch global histone deacetylase inhibitors consumption 2016 market research report.Your search for "" gave back 1533495 results.
Multiple myeloma drugs fall into various drug classes, including proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), alkylating agents,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Epigenetic Therapeutics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a...
Catalog:
GIR
October 2023
Price: USD 3,480.00
Small molecule inhibitors that block the actions of protein kinases and the associated signaling pathways can thus have significant impact The “Small...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Multiple myeloma drugs fall into various drug classes, including proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), alkylating agents,...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
These compounds are usually ≤500Da size and are often administered orally. Their small size also allows them to translocate through the plasma...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Multiple myeloma drugs fall into various drug classes, including proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), alkylating agents,...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
Toxoplasmosis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
June 2018
Price: USD 2,000.00
Summary HeyReport estimates that the Histone Deacetylase 2 market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
August 2021
Price: USD 2,000.00
Summary HeyReport estimates that the Histone Deacetylase 1 market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a...
Catalog:
HYR
August 2021
Price: USD 2,000.00
Selisistat is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor. It is selective inhibitor of SIRT1 that does not class I/...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
NAD Dependent Protein Deacetylase Sirtuin 1 - Pipeline Review, H1 2020 Summary NAD Dependent Protein Deacetylase Sirtuin 1 (SIR2 Like Protein 1 or...
Catalog:
Global Markets Direct
January 2020
Price: USD 3,500.00
Selisistat is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor. It is selective inhibitor of SIRT1 that does not class I/...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Selisistat is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor. It is selective inhibitor of SIRT1 that does not class I/...
Catalog:
GIR
February 2023
Price: USD 3,480.00
